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Variation in RNA splicing (i.e., alternative splicing) plays an important role in many diseases. Variants near 5′ and 3′ splice
sites often affect splicing, but the effects of these variants on splicing and disease have not been fully characterized beyond
the two “essential” splice nucleotides flanking each exon. Here we provide quantitative measurements of tolerance to mu-
tational disruptions by position and reference allele–alternative allele combinations. We show that certain reference alleles
are particularly sensitive to mutations, regardless of the alternative alleles into which they are mutated. Using public RNA-
seq data, we demonstrate that individuals carrying such variants have significantly lower levels of the correctly spliced tran-
script, compared to individuals without them, and confirm that these specific substitutions are highly enriched for known
Mendelian mutations. Our results propose a more refined definition of the “splice region” and offer a new way to prioritize
and provide functional interpretation of variants identified in diagnostic sequencing and association studies.
[Supplemental material is available for this article.]
RNA splicing and alternative splicing are fundamental regulatory
processes connecting transcription and translation. Splicing de-
fects have been shown to make major contributions to the allelic
architecture of numerous diseases including spinal muscular
atrophy, retinitis pigmentosa, Parkinson’s disease, familial dysau-
tonomia, schizophrenia, autism spectrum disorder and various
types of cancers (Lorson et al. 1999; Radisky et al. 2005; Ibrahim
et al. 2006; Law et al. 2007; Samaranch et al. 2010; Poulikakos et
al. 2011; Tanackovic et al. 2011; Voineagu et al. 2011; Ferrarese
et al. 2014). For example, Ferrarese et al. (2014) showed that alter-
native splicing between exon 5 and exon 7 of ANXA7 gene en-
hances EGFR signaling and contributes to cancer progression in
glioblastomas. Law et al. (2007) found higher expression levels of
ERBB4 splice variants containing metalloprotease cleavable extra-
cellular domains and PI3K binding sites in schizophrenia, and
these splice variant isoforms were also highly associated with
several risk SNP. Alternative splicing is particularly widespread in
the central nervous system and generates isoform diversity impor-
tant to neuronal development and normal functioning (Raj and
Blencowe 2015).
Many previous studies focused on howmutations affect splic-
ing. Large-scale RNA-seq studies and smaller-scale minigene-based
approaches identified hundreds of eQTLs and sQTLs (Erkelenz
et al. 2014; The GTEx Consortium 2015; Rivas et al. 2015;
Soukarieh et al. 2016), confirming awidespread influence ofmuta-
tions on splicing variation. Based on these results as well as an un-
derstanding of cis- and trans-acting elements that affect splicing
(such as branch site, polypyrimidine tract, and splicing enhancer
and silencer motifs), computational algorithms have been devel-
oped to predict the effect of mutations on both general and tis-
sue-specific splicing patterns (Barash et al. 2010; Di Giacomo
et al. 2013; Erkelenz et al. 2014; Rosenberg et al. 2015; Xiong
et al. 2015). One important goal of studying mutations affecting
splicing is to aid in the functional interpretation of the numerous
single-nucleotide variants (SNVs) identified in disease-mapping
studies (from common alleles implicated by GWAS to rare and
de novomutations found in bothMendelian and common diseas-
es). For instance, The GTEx Consortium (2015) demonstrated sig-
nificant enrichment of sQTLs in ENCODE functional domains;
Xiong et al. (2015) sifted through variants in disease candidate
genes and prioritized mutations using the predicted likelihood
that they will disrupt normal splicing, but did not find significant
enrichment of splice-disrupting variants inGWAShits. Using a dif-
ferent method to identify sQTLs, Li et al. (2016) showed that the
enrichment of sQTLs among GWAS SNPs is comparable or even
larger in some cases than that of eQTLs.
Of the variants confirmed or predicted to affect splicing,
many are outside the two ultraconserved positions at both the 5′
(donor, typically GT) and 3′ (acceptor, typically AG) splice sites
(ss). These so-called “essential” or “canonical” splice bases are cus-
tomarily included as loss-of-function annotations, while others
nearby aremost often ignored in such annotations. Establishment
of the consensus sequence motif several base pairs around the
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canonical splice sites early on (Shapiro and Senapathy 1987; Ste-
phens and Schneider 1992) provided early evidence suggesting
that additional near-splice-site bases are important. More recently,
Rivas et al. (2015) quantified the proportion of variants disrupting
splicing at ±25 bp from the splice sites based on RNA-sequencing
results, clearly demonstrating signal beyond the essential sites.
The recent availability of the ExAC data set (Lek et al. 2016), a
deep-coverage exome sequencing data set with 60,706 individuals,
permits a closer look at the near-splice-site region since standard
exome capture generally provides deep coverage 20–40 nucleo-
tides (nt) to both sides of captured coding exons. Of particular im-
portance, to assess the degree of mutational tolerance in different
genes, Lek et al. (2016) developed an expectation-maximization
approach to quantify the lack of protein-truncating variants com-
pared to expectation in each gene (the probability of being loss-of-
function intolerant, or pLI). As a result, genes with pLI value ≥0.9
(n = 3230, 17.7%) are particularly intolerant of disruptive muta-
tions. Following this line of thought, we utilized the relative inci-
dence of variation in splice regions of intolerant and tolerant genes
to characterize the deleteriousness of mutations at each individual
near-splice sites (see Methods).
Although different studies have focused on mutations in this
region, none of them directly quantified the level of deleterious-
ness ofmutationsbybothpositionsand reference/alternative allele
types. Here we offer a systematic analysis of near-splice-site muta-
tions, identifying which sites are intolerant of mutation and
confirming their impact through RNA-seq data and analysis of
knownMendelianmutations, thereby developing a refined defini-
tion of “splice region” suitable for use in disease genetics. Beyond
standard intolerance andprevious examinationof the splice region
in Rivas et al. (2015), we provide here reference nucleotide-specific
intolerance information accounting for the known referencebiases
of these positions that was not available in Rivas et al. (2015). It is
worthnoting that hereweuse humanpolymorphism rates and dis-
ease mutation occurrences to examine strong selective pressure
against mutations.
Results
We first sought to define which near-splice-site positions are
important for normal splicing. The range of near-splice sites we
focused on in all of our analyses is ±10 bp around splice junctions,
and nomenclature is shown in Figure 1A. The essential/canoni-
cal splice sites have well-known patterns GT (5′ splice site, D + 1
and D + 2) and AG (3′ splice site, A− 2 and A− 1) and are included




Figure 1. Quantification of intolerance tomutations split by positions and reference alleles. (A) Nomenclature used throughout this study; (B) χ2 statistics
at the 5′ end; (C ) χ2 statistics at the 3′ end; (D) odds ratios at the 5′ end; (E) odds ratios at the 3′ end.
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To determine potential functional significance, we used χ2
statistics and odds ratios to measure whether mutation rates at
our sites of interest are significantly lower in loss-of-function intol-
erant genes (see Methods; for an example, see Supplemental Fig.
S1). Consistent with implications from earlier RNA-seq studies,
the distribution of the χ2 statistics over ±10 bp around splice junc-
tions shows that, in addition to the four “essential splice” nucleo-
tides, positions D + 3, D + 4, D + 5, D + 6, D− 1, and A + 1 are very
significantly intolerant of mutations. χ2 statistics of exonic regions
are, as expected, on average higher than intronic regions due to
background genic mutation; even considering this background,
A + 1 and D− 1 (the initial and terminal coding nucleotides in
each exon) are unusually constrained (Supplemental Table S1).
Both χ2 statistics and odds ratios for the four reference alleles
at each near-splice-site position demonstrate that a specific refer-
ence allele is more intolerant of mutations than others at the
same positions. Figure 1, B and C, shows that reference base T at
D + 6, G at D + 5, A at D + 4 and D + 3, G at D− 1, and G at A + 1
are significantly less tolerant of mutational alteration than are
the other three reference bases at those same positions. This differ-
ence is clearly evident in the odds ratio of the variation rate be-
tween tolerant and intolerant genes (Fig. 1D,E), indicating that
the statistical excess is not simply a function of sample size.
Although, for G at A + 1, commonness of this allele does seem to
contribute to the high χ2 statistics especially when compared to
its odds ratio. Also the specificity of the G allele at this position
is not as clear cut, which is also evident in Figure 2. In the following
analyses, we name these reference bases that are particularly sensi-
tive to mutations as “constrained reference bases.”
Negative selection not only reduces the rate at which we find
variants but reduces the site frequencyof observed siteswhen com-
pared with neutral sites. To confirm the inference that selection is
acting against specific nucleotide substitutions in the splice re-
gion, we first looked at the mutability-adjusted proportion of sin-
gletons (MAPS) as proposed in Lek et al. (2016) at constrained
reference bases versus other three reference bases at the same posi-
tions (Fig. 2). If mutations changing the constrained reference bas-
es are indeed more deleterious, it is expected that there is a higher
singleton ratio among these mutations because deleterious vari-
ants tend to be rarer. Aswe are comparing different reference bases,
MAPS rather than the direct proportion of singletons is needed in
order to account for systematic mutability differences given local
nucleotide context. Consistent with the prediction from the χ2
analysis, MAPS is significantly higher at constrained reference bas-
es than at other reference bases at the same positions. Compared to
the averageMAPS of functional classes reported in Lek et al. (2016),
the constrained reference bases fall mostly between “missense var-
iant” (0.0439) and “stop gained” (0.143), confirming their func-
tional relevance. As a negative control, we also calculated MAPS
for D + 10 (a nonsignificant intronic site) as a comparator for the
D + 3 to D + 6 sites and D− 10 (an exonic site, which includes a
mixture of missense and synonymous mutations) as a comparator
for the D− 1 and A + 1 sites.
After demonstrating the importance of individual con-
strained reference bases, we were also interested in whether com-
binations of such bases enhance or modify the effect. As the
constrained reference bases are also themost common reference al-
leles at their respective positions (frequencies of respective con-
strained reference bases at D + 6, D + 5, D + 4, D + 3, D− 1, and
A + 1 are 0.49, 0.77, 0.7, 0.62, 0.8, and 0.49, respectively), we hy-
pothesized that they together form a consistent pattern. Since all
of the constrained reference bases except for A + 1 are on the 5′
side of the intron, we tested whether mutations disrupting
the pattern at the 5′ side tend to co-occur. More specifically, we
used the Breslow-Day test on a three-way contingency table
(Breslow and Day 1980) to study whether the presence of one con-
strained reference base-disrupting mutation (“Independent Pos”)
modifies the odds ratios of such mutations occurring nearby
(“Combination Pos”). An example three-way contingency table
as well as the results are in Supplemental Table S2. For each of
the independent positions, we tested for both its effect on one spe-
cific nearby position (only one position listed as the combination
position) and on any of the nearby positions (more than one posi-
tion listed as the combination position). Althoughmutations gen-
erally act independently (i.e., the presence of a mutation
disrupting the constrained reference base does not affect chances
of nearby similar mutations; Breslow-Day test P-value >0.05), we
do observe a general property that some mutations (particularly
those disrupting the D + 5 T, D + 3 A, or D− 1 G alleles) signifi-
cantly reduce the impact of additional mutations. This may sug-
gest that individual disruptions to a consensus motif are
sufficient to disturb splicing—but could also reflect that some of
the observed disruptions in constrained genes in reference data-
bases might be relatively benign owing to the availability of a suit-
able backup splice site, and thus not additionally punished by the
presence of a second mutation.
One of the first steps of the splicing process is the recognition
of 5′ss byU1 snRNP,which is one of the five snRNPsmaking up the
spliceosome. Later on, U1 will be replaced by U6, which brings the
5′ss and the branch point closer together to prepare for the first cat-
alytic reaction. Therefore, we speculate that any mutation disrupt-
ing the G (GT) AAGT motif (i.e., disrupting the constrained
reference bases) on the 5′ side would disrupt U1 and U6 snRNP
binding, which in turn leads to abnormal splicing.
Given the clear evidence that natural selection does not toler-
ate substitutions in these “near-splice” regions in genes generally
sensitive to heterozygous mutation, we then sought to character-
ize the functional effects on splicing and genetic impact on disease
risk contributed by these variants. The availability of GTEx and
Figure 2. Singleton ratios adjusted by mutability at near-splice sites (left
panel) compared to ExAC missense, nonsense (middle panel), and mis-
sense split by CADD (right panel) as references. “D+ 10” and “D− 10” rep-
resent singleton ratios from an arbitrary intronic site and an arbitrary
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GEUVADIS data provides an excellent opportunity to examine the
effect of mutations at near-splice sites on splicing (Lappalainen
et al. 2013; The GTEx Consortium 2015). Specifically, we tested
if heterozygous carriers of variants changing the constrained refer-
ence bases resulted in significantly less correct splice junction
reads compared to the homozygous reference allele carriers, with
correct splice junction reads defined as the number of split-map-
ping reads consistent with canonical transcript structure normal-
ized to sequencing depth and standardized to population level.
Wilcoxon test shows that this is indeed the case for D + 6, D + 5,
D + 4, and D− 1 (Table 1). As a negative control, the same tests
for unconstrained reference bases at the same locations do not
show a statistically significant result. These results strongly sup-
port the idea that mutations changing the constrained reference
bases disrupt splicing and are less tolerated. To better understand
this effect, we also calculated the correlations between MAPS of
constraint reference alleles and effect sizes of splicing disruption
(Pearson’s correlation coefficient = 0.165 for GTEx and −0.592
for GEUVADIS). Although correlation in GTEx is weak, there is a
strong negative correlation betweenMAPS and effect sizes of splic-
ing disruption in GEUVADIS (constrained reference bases with
higher MAPS also tend to have stronger negative effect on normal
splicing). Beyond splicing disruption, no clear patterns of alterna-
tive splicing subtypes can be determined.
Although it would be very helpful to include the four essen-
tial nucleotides for comparison in Table 1, we did not have suffi-
cient data to carry out the tests, because they rely on having a
sufficient number of common polymorphic sites in GTEx and
GEUVADIS to explore the effect of mutation and on having alter-
natives to the reference as negative controls for the assertion that
mutation of a particular conserved reference site was functionally
relevant.
After confirming their impact on splicing, we next explored
the impact these specific substitutions have on known, largely
Mendelian, diseases. In the ClinVar data set, mutations are as-
signed clinical significance categories based on different levels of
evidence. Taking clinical significance categories “likely pathogen-
ic,” “pathogenic,” “risk factor,” and “association” as the deleteri-
ous group (39.3% of all variants within 10 bp to the splice sites)
and categories “benign” and “likely benign” as the benign group,
we found thatmutations changing the constrained reference bases
are significantly enriched in the deleterious group but not the
benign group (Table 2). This result further supports the idea that
mutations changing the constrained reference alleles are more
likely to be disease-related.
In addition toMendelianand rare diseases,mutationsdisrupt-
ing the constrained reference alleles are also pathogenic in com-
mon diseases. For instance, a loss-of-function variant in ABCA7
gene (rs200538373, D + 5G >C) confers risk to Alzheimer’s disease
(Steinberg et al. 2015). A group of variants with themajority fitting
pattern D− 1G >H, collectively named as “last-base exonic muta-
tions” (LBEMs) by the authors, were found to be themost frequent
mutation type disrupting normal splicing in several cancer
types and enriched in tumor suppressor genes such as TP53 (Jung
et al. 2015).
These findings can be used to better annotate potential
strong-acting mutations in established disease genes. As an exam-
ple, we looked at a curated list of genes having more than three de
novo protein-truncating variants each from the published studies
of de novo variation in autism spectrum disorder, developmental
delay (DD), and intellectual disability (ID), which have recently
been jointly analyzed (Kosmicki et al. 2017). Ten genes also harbor
at least one de novo near-splice-site variant at the key positions
identified above, indicating that these near-splice-site variants
may have a strong role in disease pathology (Supplemental Table
S3). Additionally, five genes (NCKAP1, NIN, EFTUD2, HNRNPK,
and KDM6B) that have two protein-truncating variants each har-
bor a near-splice-site variant at key positions, pushing these genes
into the more convincing disease-related range.
To estimate the overall addition to disease mutation annota-
tions by taking into account the constrained reference bases, we
compared the number of credible deleterious mutations occurring
at the essential splice sites versus the constrained reference bases at
near-splice sites in ClinVar and the de novo variant data sets.
AmongClinVar variants thatmeet the clinical significance catego-
ry criteria mentioned above, 1284 and 973 mutations disrupt the
5′ and 3′ essential splice sites, respectively. In comparison, 806mu-
tations disrupt the six constrained references bases (D + 3 A allele:
61; D + 4 A allele: 27; D + 5 G allele: 181; D + 6 T allele: 19; D− 1 G
allele: 372; A + 1 G allele: 146). In the de novo variant data sets in-
cluding both autism and DD/ID individuals, 59 and 39 de novo
variants occur at the 5′ and 3′ essential splice sites and a total of
35 mutations occur at the constrained reference bases in genes
with pLI≥ 0.9. Overall, ∼36%more mutations in the splice region
acquire new functional annotations if we take specifically intoler-
ant splice junction mutations into account.
Discussion
Variants outside splice sites are known to affect splicing, but a de-
tailed evaluation of which mutations at nonessential sites near
splice junctions affect splicing, and to what degree these contrib-
ute to disease, is still lacking. Our study provides a quantitative
measure of the deleteriousness of mutations in near-splice sites
and shows that tolerance to mutations is reference allele specific.
To validate this inference from the initial analysis, we showed
that amutability-adjusted proportion of singletons (a site-frequen-
cy–basedmetric correlatedwith negative selective pressure) at con-
strained reference bases are significantly higher compared to other
reference bases at the same positions, and then we further used
RNA-sequencing data from GEUVADIS and GTEx studies to show
that mutations changing constrained reference bases resulted in
significantly fewer correctly spliced reads. Importantly, we addi-
tionally confirmed thatmutations changing the constrained refer-
ence bases are significantly enriched in ClinVar variants andmake
Table 1. Comparison of the number of correct splice junction reads
between mutation carriers and homozygous reference individuals in
GTEx and GEUVADIS studies





D + 6 T A/C/G GTEx 0.836 0.01635
GEUVADIS 0.899 0.04739
D + 5 G A/C/T GTEx 0.705 8.67 × 10−8
GEUVADIS 0.621 0.0001732
D + 4 A T/C/G GTEx 0.832 0.0004388
GEUVADIS 0.767 0.1157
D + 3 A T/C/G GTEx N/A N/A
GEUVADIS N/A N/A
D− 1 G A/C/T GTEx 0.913 1.06 × 10−13
GEUVADIS 0.76 0.008005
A + 1 G A/C/T GTEx N/A N/A
GEUVADIS N/A N/A
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a meaningful addition to the allelic architecture of rare disease. In
summary, by providing a detailed analysis of selective pressure and
impact on splicing, we propose a refinement to the “splice region”
definition suitable for use in Mendelian and complex disease
exome analysis. As the specific pairings of positions and reference
alleles have high impact on normal splicing if disrupted, they can
therefore be used to prioritize and provide functional interpreta-
tions for mutations identified in association-type studies.
In contrast, genome interpretation at present often annotates
but quite frequently ignores the vastly larger, and largely benign,
category of any variant in the “splice region” within 10 or 20 bp
of a splice junction—the annotation suggested here will enable a
stronger consequence be attached to a much smaller number of
variants. Specifically, surveying ExAC, we find that an average par-
ticipant sampled contains 2918.6 variants in the splice region
(within 10 bp of the splice junction)—only 106 of which are in
the refined set of nucleotides and reference alleles listed here,
and only 20.4 (0.7% of all near-splice-site mutations) are in genes
with pLI≥ 0.9. Restricting to only rare variants with MAF < 0.01,
this number further drops to 1.28 mutations per individual. In
clinical exome evaluation, therefore, rather than a general but un-
certain consideration of variants “near splice junctions,” the re-
fined set of sites and reference nucleotides identified in this
study are demonstrated (Fig. 2; Table 2) as a category to confer
risk comparable to damagingmissense variants and should be con-
sidered similarly in evaluating plausible causal mutations.
Instead of using the constrained reference alleles criteria inde-
pendently, one interesting question is whether it is possible to
incorporate these positions into existing scores thatmeasuremuta-
tion/gene deleteriousness, for example the pLI.We note that since
the number of sites involved is not so large compared to potential
nonsense plus essential splice nucleotides, the additional infor-
mation would not make a very substantial difference. Indeed as
the ExAC and other resources increase in size, particular splicing
intolerance metrics should become an interesting possibility.
One limitation of our study is that we only considered varia-
tion at canonical transcripts. Although we used canonical tran-
scripts to capture overall deleteriousness of mutations at near-
splice sites, to fully understand splicing in the context of specific
diseases, it would be best to look at tissue-specific transcripts and
isoforms.
Methods
We defined “near-splice-site regions” as ±10 bp around the 5′ and
3′ splice sites. For all the subsequent analysis, only canonical tran-
scripts were considered (GENCODE v19). See Figure 1A for addi-
tional nomenclature used throughout.
We used variation from the ExAC data set (version 0.3; http://
exac.broadinstitute.org) mapped to human reference genome
(hg19) to scan for evidence of selection against variation in the
near-splice-site regions. First, we tallied the number of A, T, C,
and G’s in the reference genome at each near-splice-site position
across all canonical exons along with the number of variants ob-
served in ExAC, correcting the numbers by coverage following pre-
vious methods (Lek et al. 2016) in order to account for variants
missed due to lower sequencing coverage. Briefly, the reference al-
lele count at each base pair is multiplied by a factor determined by
the median of coverage at that position. If median coverage >50,
factor = 1; if 1≤median coverage≤ 50, factor = 0.089 + 0.217 × log
(median coverage); if median coverage < 1, factor = 0.089. The cor-
rected number of reference bases as well as number of mutations
by reference and alternative allele are shown in Supplemental
Table S1.
The probability of a gene being loss-of-function intolerant
(pLI) was developed in Lek et al. (2016) by comparing observed
with expected rates of truncating mutations and identified that
in 15%–20% of genes, such mutations are under strong selection
consistent with that seen in severeMendelianhaploinsufficiencies
(Lek et al. 2016; Cassa et al. 2017). Analyses that followed compar-
ing loss-of-function intolerant (pLI≥ 0.9, n = 3230) genes with
others (Genovese et al. 2016; Lek et al. 2016; Kosmicki et al.
2017) established that indeed heterozygous truncating mutations
(nonsense, frameshift, and essential splice site mutations) in these
genes often have significant medical consequences. We therefore
theorized that any splice-region variants (beyond the essential
splice sites) disrupting normal gene function should also be signif-
icantly depleted in loss-of-function intolerant genes. Thus we
asked whether rates of mutations near splice junctions were signif-
icantly different between the same two groups of genes (LoF-toler-
ant and LoF-intolerant). We created a contingency table according
to gene group (pLI < 0.9 versus pLI≥ 0.9) and mutation count
(number of bases with mutations versus number of bases lacking
mutation, corrected for coverage) for each reference allele-alterna-
tive allele combination and calculated the Pearson’s χ2 statistic
(Agresti 2007). We noticed that at some positions, the χ2 statistics
are consistently high for mutations from a specific reference allele
regardless of the alternative allele to which they mutate; we also
created a Pearson’s χ2 statistic for each reference base at all posi-
tions (Supplemental Table S1). An example of the per-reference-
base contingency table (D + 6 T allele) is in Supplemental Figure S1.
One caveat with comparing Pearson’s χ2 statistics of different
reference allele-alternative allele combinations directly is that this
statistic increases as counts in contingency tables increase (reflect-
ingmore power to detect distortions when sample size is larger). In
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D + 6 0.325 19 1 7.35 × 10−9 19 75 0.997
D + 5 0.74 181 1 <2.2 × 10−16 21 22 0.999
D + 4 0.438 26 1 7.44 × 10−9 5 44 1
D + 3 0.544 60 17 1.58 × 10−5 24 18 0.42
D− 1 0.697 372 39 <2.2 × 10−16 83 170 1
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other words, more common reference alleles tend to have higher
statistics. Although the level of significance that we observe is
well abovewhat can be explained by commonness of alleles alone,
we report odds ratios to better quantify the differences inmutation
rates in the two groups of genes.
Since nucleotide context is such a major determinant of mu-
tation rate, we used the mutability-adjusted proportion of sin-
gletons (MAPS) as calculated in Lek et al. (2016). Briefly, the
singleton ratio at eachmutational site is adjusted by the mean sin-
gleton ratio of allmutations surrounded by the same 3-nt sequence
context. We compared MAPS of mutations changing reference al-
leles with particularly high χ2 statistics and odds ratios (named as
constrained reference bases) and other reference alleles in the
splice regionwith that of ExACmissense and nonsensemutations,
as well as ExACmissense mutations split by CADD categories, tak-
en from Lek et al. (2016) directly.
RNA-seq analysis was carried out using GTEx and GEUVADIS
data sets, with quality control and mapping steps completed as
part of the respective project. For GTEx, the pilot phase and tissue
types adipose tissues, artery tibial, heart left ventricle, lung, skele-
tal muscle, nerve tibial, sun-exposed skin, thyroid, and blood were
used. Theses tissues were used because they have the highest num-
bers of samples in GTEx. To test whether mutations identified as
deleterious frommutational data alone have an effect on splicing,
themedian of correct splice junction reads was compared between
individuals carrying a mutation disrupting one of the constrained
reference bases and individuals that are homozygous (for the con-
strained reference bases) byWilcoxon rank-sum test. Correct splice
junction reads were defined as the number of split-mapping reads
consistent with structures of canonical transcripts normalized by
sequencing depth and standardized to the population level.
Mutations from different exons and genes are combined by their
relative positions and disrupted reference alleles, and for each indi-
vidual carrying a mutation, a homozygous wild-type individual is
sampled from the population. Identical analyses at variation at un-
constrained reference nucleotides (thus matched for DNA varia-
tion content compared to reference) were performed, and no
deviation from 50–50 allele balance among heterozygote carriers
was observed, thereby establishing no impact of DNA variation
on read mapping efficiency. A “N/A” result was reported when
there was not enough data to perform the test. Effect sizes (odds ra-
tios of an individual being heterozygous as opposed to homozy-
gous as correct splice junction reads increase) were also reported.
We tried to categorize the kind of alternative splicing events
associated with the constrained reference base-disrupting muta-
tions into one of exon skipping, exon elongations/reading into in-
tron, or a mixture of the above, but no clear pattern was shown as
to whether a particular event type is preferred. The results of this
exploration and methods can be found in the supplemental text
of Rivas et al. (2015). Briefly, a Gaussian mixture model was used
to classify alternative splicing event types based on expression val-
ues of the nearest exon and intron of themutation. In general, it is
difficult to classify the type of event with great certainty at the cur-
rent sequencing depth of GEUVADIS and GTEx.
TheClinVar data setwas downloaded fromhttps://www.ncbi.
nlm.nih.gov/clinvar/docs/maintenance_use/ (accessed February
2016). Excesses of disease-causing variants were calculated using
variants with clinical significance categories “likely pathogenic,”
“pathogenic,” “risk factor,” and “association.” We tested for the
enrichment of mutations changing constrained reference alleles
in ClinVar variants with a binomial test comparing proportions
of mutations with constrained reference alleles with that in the ge-
neral population (ExAC, including both pLI≥ 0.9 and pLI < 0.9
genes). Since the samenucleotides at the same positionswere com-
pared, frequency differences of the four reference alleles at each po-
sition were implicitly accounted for. A one-tailed test was used
because the alternative hypothesis is that the true proportions of
such mutations in ClinVar are higher than those naturally occur-
ring in the general population. We also tested for enrichment in
“benign/likely benign” categories as a negative control.
In all our analyses, reference versus alternative alleles were
used instead of major versus minor alleles. Given the fact that
the reference allele and major allele are the same for the vast ma-
jority of variants (e.g., 99.78% in ExAC), switching between using
reference alleles and major alleles does not significantly change
our results and does not change at all the primary analyses of
ClinVar and ultra-rare/de novo mutations in neurodevelopmental
disease.
In all the data sets used, reads were mapped to human refer-
ence genome GRCh37/hg19. Although GRCh38 is the most
updated assembly with improvements in the mitochondrial ge-
nome and the centromeres, our results do not depend on these
regions. Additionally, the number of nucleotides corrected in
GRCh38 is relatively small and there is no reason to believe that
they are enriched in the near-splice-site region of canonical tran-
scripts. Therefore, we feel that usingGRCh38will not significantly
change our results.
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